BIOMET RECONSTRUCTIVE DEVICE SALES JUMP 13%
This article was originally published in The Gray Sheet
Executive Summary
BIOMET RECONSTRUCTIVE DEVICE SALES JUMP 13%, outpacing the company's 10.7% gain for total sales in the first quarter. Sales of reconstructive devices, which consist primarily of products for knee, hip and shoulder replacement, were $56.1 mil. during the quarter. The company singled out its Maxim Total Knee System, saying that the product "continued to capture market share in the domestic total knee market."